Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Bay Area Reporter (San Francisco) (11.19.09) - Friday, November 20, 2009
Seth Hemmelgarn
The first study will examine mobile phone text-messaging to improve treatment adherence among HIV patients who face complex regimens. More than 250 participants from San Francisco General Hospital's Positive Health Program will be involved, said Dr. James S. Kahn, a professor of clinical medicine in the UCSF program.
The method has been tried before, "but not for our patients, who are on the opposite side of the digital divide and who don't have as many resources as other persons receiving health care," Kahn said. "We'll know whether this is useful or not within two years."
The second study will test the feasibility and acceptability of a self-administered, Web-based drug and alcohol intervention to improve HIV treatment adherence and prevent transmission. The strategy involves patients screening for drug and alcohol use, a brief intervention and referral for treatment (SBIRT). In one SBIRT group, patients will be able to access information securely online from their own medical records. This will be compared with a provider-administered protocol during clinic appointments.
"We are hoping to find out whether patients are more open to responding to sensitive topics with a self-administered, Web- based approach than they are talking directly with their clinician," said Carol Dawson-Rose, an associate nursing professor at UCSF's Center for AIDS Prevention Studies.
091120
AD091995
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.